Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
25,125
archived clinical trials in
Diabetes

Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
A Phase 2, Randomized, Double-Blind, Double-Dummy Placebo-and Active-Controlled, Multicenter Study to Determine the Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/13/2016
Clinical Research Facility
mi
from
Birmingham, AL
Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
A Phase 2, Randomized, Double-Blind, Double-Dummy Placebo-and Active-Controlled, Multicenter Study to Determine the Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/13/2016
Clinical Research Facility
mi
from
Birmingham, AL
Click here to add this to my saved trials
Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
A Phase 2, Randomized, Double-Blind, Double-Dummy Placebo-and Active-Controlled, Multicenter Study to Determine the Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/13/2016
Clinical Research Facility
mi
from
Hoover, AL
Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
A Phase 2, Randomized, Double-Blind, Double-Dummy Placebo-and Active-Controlled, Multicenter Study to Determine the Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/13/2016
Clinical Research Facility
mi
from
Hoover, AL
Click here to add this to my saved trials
Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
A Phase 2, Randomized, Double-Blind, Double-Dummy Placebo-and Active-Controlled, Multicenter Study to Determine the Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/13/2016
Clinical Research Facility
mi
from
Tucson, AZ
Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
A Phase 2, Randomized, Double-Blind, Double-Dummy Placebo-and Active-Controlled, Multicenter Study to Determine the Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/13/2016
Clinical Research Facility
mi
from
Tucson, AZ
Click here to add this to my saved trials
Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
A Phase 2, Randomized, Double-Blind, Double-Dummy Placebo-and Active-Controlled, Multicenter Study to Determine the Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/13/2016
Clinical Research Facility
mi
from
Anaheim, CA
Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
A Phase 2, Randomized, Double-Blind, Double-Dummy Placebo-and Active-Controlled, Multicenter Study to Determine the Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/13/2016
Clinical Research Facility
mi
from
Anaheim, CA
Click here to add this to my saved trials
Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
A Phase 2, Randomized, Double-Blind, Double-Dummy Placebo-and Active-Controlled, Multicenter Study to Determine the Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/13/2016
Clinical Research Facility
mi
from
Burlingame, CA
Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
A Phase 2, Randomized, Double-Blind, Double-Dummy Placebo-and Active-Controlled, Multicenter Study to Determine the Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/13/2016
Clinical Research Facility
mi
from
Burlingame, CA
Click here to add this to my saved trials
Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
A Phase 2, Randomized, Double-Blind, Double-Dummy Placebo-and Active-Controlled, Multicenter Study to Determine the Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/13/2016
Clinical Research Facility
mi
from
Chula Vista, CA
Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
A Phase 2, Randomized, Double-Blind, Double-Dummy Placebo-and Active-Controlled, Multicenter Study to Determine the Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/13/2016
Clinical Research Facility
mi
from
Chula Vista, CA
Click here to add this to my saved trials
Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
A Phase 2, Randomized, Double-Blind, Double-Dummy Placebo-and Active-Controlled, Multicenter Study to Determine the Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/13/2016
Clinical Research Facility
mi
from
Fresno, CA
Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
A Phase 2, Randomized, Double-Blind, Double-Dummy Placebo-and Active-Controlled, Multicenter Study to Determine the Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/13/2016
Clinical Research Facility
mi
from
Fresno, CA
Click here to add this to my saved trials
Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
A Phase 2, Randomized, Double-Blind, Double-Dummy Placebo-and Active-Controlled, Multicenter Study to Determine the Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/13/2016
Clinical Research Facility
mi
from
Los Angeles, CA
Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
A Phase 2, Randomized, Double-Blind, Double-Dummy Placebo-and Active-Controlled, Multicenter Study to Determine the Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/13/2016
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
A Phase 2, Randomized, Double-Blind, Double-Dummy Placebo-and Active-Controlled, Multicenter Study to Determine the Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/13/2016
Clinical Research Facility
mi
from
Los Gatos, CA
Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
A Phase 2, Randomized, Double-Blind, Double-Dummy Placebo-and Active-Controlled, Multicenter Study to Determine the Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/13/2016
Clinical Research Facility
mi
from
Los Gatos, CA
Click here to add this to my saved trials
Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
A Phase 2, Randomized, Double-Blind, Double-Dummy Placebo-and Active-Controlled, Multicenter Study to Determine the Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/13/2016
Clinical Research Facility
mi
from
Norwalk, CA
Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
A Phase 2, Randomized, Double-Blind, Double-Dummy Placebo-and Active-Controlled, Multicenter Study to Determine the Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/13/2016
Clinical Research Facility
mi
from
Norwalk, CA
Click here to add this to my saved trials
Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
A Phase 2, Randomized, Double-Blind, Double-Dummy Placebo-and Active-Controlled, Multicenter Study to Determine the Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/13/2016
Clinical Research Facility
mi
from
Orange, CA
Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
A Phase 2, Randomized, Double-Blind, Double-Dummy Placebo-and Active-Controlled, Multicenter Study to Determine the Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/13/2016
Clinical Research Facility
mi
from
Orange, CA
Click here to add this to my saved trials
Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
A Phase 2, Randomized, Double-Blind, Double-Dummy Placebo-and Active-Controlled, Multicenter Study to Determine the Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/13/2016
Clinical Research Facility
mi
from
Colorado Springs, CO
Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
A Phase 2, Randomized, Double-Blind, Double-Dummy Placebo-and Active-Controlled, Multicenter Study to Determine the Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/13/2016
Clinical Research Facility
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
A Phase 2, Randomized, Double-Blind, Double-Dummy Placebo-and Active-Controlled, Multicenter Study to Determine the Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/13/2016
Clinical Research Facility
mi
from
Pueblo, CO
Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
A Phase 2, Randomized, Double-Blind, Double-Dummy Placebo-and Active-Controlled, Multicenter Study to Determine the Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/13/2016
Clinical Research Facility
mi
from
Pueblo, CO
Click here to add this to my saved trials
Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
A Phase 2, Randomized, Double-Blind, Double-Dummy Placebo-and Active-Controlled, Multicenter Study to Determine the Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/13/2016
Clinical Research Facility
mi
from
Boca Raton, FL
Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
A Phase 2, Randomized, Double-Blind, Double-Dummy Placebo-and Active-Controlled, Multicenter Study to Determine the Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/13/2016
Clinical Research Facility
mi
from
Boca Raton, FL
Click here to add this to my saved trials
Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
A Phase 2, Randomized, Double-Blind, Double-Dummy Placebo-and Active-Controlled, Multicenter Study to Determine the Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/13/2016
Clinical Research Facility
mi
from
Clearwater, FL
Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
A Phase 2, Randomized, Double-Blind, Double-Dummy Placebo-and Active-Controlled, Multicenter Study to Determine the Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/13/2016
Clinical Research Facility
mi
from
Clearwater, FL
Click here to add this to my saved trials
Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
A Phase 2, Randomized, Double-Blind, Double-Dummy Placebo-and Active-Controlled, Multicenter Study to Determine the Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/13/2016
Clinical Research Facility
mi
from
Hialeah, FL
Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
A Phase 2, Randomized, Double-Blind, Double-Dummy Placebo-and Active-Controlled, Multicenter Study to Determine the Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/13/2016
Clinical Research Facility
mi
from
Hialeah, FL
Click here to add this to my saved trials
Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
A Phase 2, Randomized, Double-Blind, Double-Dummy Placebo-and Active-Controlled, Multicenter Study to Determine the Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/13/2016
Clinical Research Facility
mi
from
Jupiter, FL
Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
A Phase 2, Randomized, Double-Blind, Double-Dummy Placebo-and Active-Controlled, Multicenter Study to Determine the Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/13/2016
Clinical Research Facility
mi
from
Jupiter, FL
Click here to add this to my saved trials
Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
A Phase 2, Randomized, Double-Blind, Double-Dummy Placebo-and Active-Controlled, Multicenter Study to Determine the Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/13/2016
Clinical Research Facility
mi
from
Miami, FL
Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
A Phase 2, Randomized, Double-Blind, Double-Dummy Placebo-and Active-Controlled, Multicenter Study to Determine the Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/13/2016
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
A Phase 2, Randomized, Double-Blind, Double-Dummy Placebo-and Active-Controlled, Multicenter Study to Determine the Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/13/2016
Clinical Research Facility
mi
from
New Port Richey, FL
Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
A Phase 2, Randomized, Double-Blind, Double-Dummy Placebo-and Active-Controlled, Multicenter Study to Determine the Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/13/2016
Clinical Research Facility
mi
from
New Port Richey, FL
Click here to add this to my saved trials
Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
A Phase 2, Randomized, Double-Blind, Double-Dummy Placebo-and Active-Controlled, Multicenter Study to Determine the Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/13/2016
Clinical Research Facility
mi
from
Ocala, FL
Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
A Phase 2, Randomized, Double-Blind, Double-Dummy Placebo-and Active-Controlled, Multicenter Study to Determine the Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/13/2016
Clinical Research Facility
mi
from
Ocala, FL
Click here to add this to my saved trials
Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
A Phase 2, Randomized, Double-Blind, Double-Dummy Placebo-and Active-Controlled, Multicenter Study to Determine the Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/13/2016
Clinical Research Facility
mi
from
Panama City, FL
Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
A Phase 2, Randomized, Double-Blind, Double-Dummy Placebo-and Active-Controlled, Multicenter Study to Determine the Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/13/2016
Clinical Research Facility
mi
from
Panama City, FL
Click here to add this to my saved trials
Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
A Phase 2, Randomized, Double-Blind, Double-Dummy Placebo-and Active-Controlled, Multicenter Study to Determine the Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/13/2016
Clinical Research Facility
mi
from
Pembroke Pines, FL
Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
A Phase 2, Randomized, Double-Blind, Double-Dummy Placebo-and Active-Controlled, Multicenter Study to Determine the Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/13/2016
Clinical Research Facility
mi
from
Pembroke Pines, FL
Click here to add this to my saved trials
Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
A Phase 2, Randomized, Double-Blind, Double-Dummy Placebo-and Active-Controlled, Multicenter Study to Determine the Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/13/2016
Clinical Research Facility
mi
from
Tampa, FL
Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
A Phase 2, Randomized, Double-Blind, Double-Dummy Placebo-and Active-Controlled, Multicenter Study to Determine the Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/13/2016
Clinical Research Facility
mi
from
Tampa, FL
Click here to add this to my saved trials
Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
A Phase 2, Randomized, Double-Blind, Double-Dummy Placebo-and Active-Controlled, Multicenter Study to Determine the Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/13/2016
Clinical Research Facility
mi
from
Sandy Springs, GA
Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
A Phase 2, Randomized, Double-Blind, Double-Dummy Placebo-and Active-Controlled, Multicenter Study to Determine the Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/13/2016
Clinical Research Facility
mi
from
Sandy Springs, GA
Click here to add this to my saved trials
Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
A Phase 2, Randomized, Double-Blind, Double-Dummy Placebo-and Active-Controlled, Multicenter Study to Determine the Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/13/2016
Clinical Research Facility
mi
from
Honolulu, HI
Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
A Phase 2, Randomized, Double-Blind, Double-Dummy Placebo-and Active-Controlled, Multicenter Study to Determine the Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/13/2016
Clinical Research Facility
mi
from
Honolulu, HI
Click here to add this to my saved trials
Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
A Phase 2, Randomized, Double-Blind, Double-Dummy Placebo-and Active-Controlled, Multicenter Study to Determine the Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/13/2016
Clinical Research Facility
mi
from
Chicago, IL
Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
A Phase 2, Randomized, Double-Blind, Double-Dummy Placebo-and Active-Controlled, Multicenter Study to Determine the Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/13/2016
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
A Phase 2, Randomized, Double-Blind, Double-Dummy Placebo-and Active-Controlled, Multicenter Study to Determine the Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/13/2016
mi
from
La Grange, IL
Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
A Phase 2, Randomized, Double-Blind, Double-Dummy Placebo-and Active-Controlled, Multicenter Study to Determine the Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/13/2016
mi
from
La Grange, IL
Click here to add this to my saved trials
Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
A Phase 2, Randomized, Double-Blind, Double-Dummy Placebo-and Active-Controlled, Multicenter Study to Determine the Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/13/2016
Clinical Research Facility
mi
from
Sunset, LA
Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
A Phase 2, Randomized, Double-Blind, Double-Dummy Placebo-and Active-Controlled, Multicenter Study to Determine the Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/13/2016
Clinical Research Facility
mi
from
Sunset, LA
Click here to add this to my saved trials
Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
A Phase 2, Randomized, Double-Blind, Double-Dummy Placebo-and Active-Controlled, Multicenter Study to Determine the Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/13/2016
Clinical Research Facility
mi
from
Portland, ME
Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
A Phase 2, Randomized, Double-Blind, Double-Dummy Placebo-and Active-Controlled, Multicenter Study to Determine the Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/13/2016
Clinical Research Facility
mi
from
Portland, ME
Click here to add this to my saved trials
Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
A Phase 2, Randomized, Double-Blind, Double-Dummy Placebo-and Active-Controlled, Multicenter Study to Determine the Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/13/2016
mi
from
Parkville, MD
Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
A Phase 2, Randomized, Double-Blind, Double-Dummy Placebo-and Active-Controlled, Multicenter Study to Determine the Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/13/2016
mi
from
Parkville, MD
Click here to add this to my saved trials
Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
A Phase 2, Randomized, Double-Blind, Double-Dummy Placebo-and Active-Controlled, Multicenter Study to Determine the Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/13/2016
Clinical Research Facility
mi
from
Rockville, MD
Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
A Phase 2, Randomized, Double-Blind, Double-Dummy Placebo-and Active-Controlled, Multicenter Study to Determine the Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/13/2016
Clinical Research Facility
mi
from
Rockville, MD
Click here to add this to my saved trials
Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
A Phase 2, Randomized, Double-Blind, Double-Dummy Placebo-and Active-Controlled, Multicenter Study to Determine the Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/13/2016
Clinical Research Facility
mi
from
Southfield, MI
Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
A Phase 2, Randomized, Double-Blind, Double-Dummy Placebo-and Active-Controlled, Multicenter Study to Determine the Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/13/2016
Clinical Research Facility
mi
from
Southfield, MI
Click here to add this to my saved trials
Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
A Phase 2, Randomized, Double-Blind, Double-Dummy Placebo-and Active-Controlled, Multicenter Study to Determine the Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/13/2016
Clinical Research Facility
mi
from
Olive Branch, MS
Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
A Phase 2, Randomized, Double-Blind, Double-Dummy Placebo-and Active-Controlled, Multicenter Study to Determine the Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/13/2016
Clinical Research Facility
mi
from
Olive Branch, MS
Click here to add this to my saved trials
Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
A Phase 2, Randomized, Double-Blind, Double-Dummy Placebo-and Active-Controlled, Multicenter Study to Determine the Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/13/2016
Clinical Research Facility
mi
from
Saint Louis, MO
Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
A Phase 2, Randomized, Double-Blind, Double-Dummy Placebo-and Active-Controlled, Multicenter Study to Determine the Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/13/2016
Clinical Research Facility
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
A Phase 2, Randomized, Double-Blind, Double-Dummy Placebo-and Active-Controlled, Multicenter Study to Determine the Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/13/2016
Clinical Research Facility
mi
from
Las Vegas, NV
Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
A Phase 2, Randomized, Double-Blind, Double-Dummy Placebo-and Active-Controlled, Multicenter Study to Determine the Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/13/2016
Clinical Research Facility
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
A Phase 2, Randomized, Double-Blind, Double-Dummy Placebo-and Active-Controlled, Multicenter Study to Determine the Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/13/2016
Clinical Research Facility
mi
from
Berlin, NJ
Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
A Phase 2, Randomized, Double-Blind, Double-Dummy Placebo-and Active-Controlled, Multicenter Study to Determine the Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/13/2016
Clinical Research Facility
mi
from
Berlin, NJ
Click here to add this to my saved trials
Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
A Phase 2, Randomized, Double-Blind, Double-Dummy Placebo-and Active-Controlled, Multicenter Study to Determine the Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/13/2016
Clinical Research Facility
mi
from
Camden, NJ
Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
A Phase 2, Randomized, Double-Blind, Double-Dummy Placebo-and Active-Controlled, Multicenter Study to Determine the Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/13/2016
Clinical Research Facility
mi
from
Camden, NJ
Click here to add this to my saved trials
Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
A Phase 2, Randomized, Double-Blind, Double-Dummy Placebo-and Active-Controlled, Multicenter Study to Determine the Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/13/2016
Clinical Research Facility
mi
from
West Seneca, NY
Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
A Phase 2, Randomized, Double-Blind, Double-Dummy Placebo-and Active-Controlled, Multicenter Study to Determine the Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/13/2016
Clinical Research Facility
mi
from
West Seneca, NY
Click here to add this to my saved trials
Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
A Phase 2, Randomized, Double-Blind, Double-Dummy Placebo-and Active-Controlled, Multicenter Study to Determine the Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/13/2016
Clinical Research Facility
mi
from
Asheboro, NC
Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
A Phase 2, Randomized, Double-Blind, Double-Dummy Placebo-and Active-Controlled, Multicenter Study to Determine the Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/13/2016
Clinical Research Facility
mi
from
Asheboro, NC
Click here to add this to my saved trials
Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
A Phase 2, Randomized, Double-Blind, Double-Dummy Placebo-and Active-Controlled, Multicenter Study to Determine the Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/13/2016
Clinical Research Facility
mi
from
Burlington, NC
Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
A Phase 2, Randomized, Double-Blind, Double-Dummy Placebo-and Active-Controlled, Multicenter Study to Determine the Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/13/2016
Clinical Research Facility
mi
from
Burlington, NC
Click here to add this to my saved trials
Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
A Phase 2, Randomized, Double-Blind, Double-Dummy Placebo-and Active-Controlled, Multicenter Study to Determine the Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/13/2016
Clinical Research Facility
mi
from
Charlotte, NC
Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
A Phase 2, Randomized, Double-Blind, Double-Dummy Placebo-and Active-Controlled, Multicenter Study to Determine the Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/13/2016
Clinical Research Facility
mi
from
Charlotte, NC
Click here to add this to my saved trials
Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
A Phase 2, Randomized, Double-Blind, Double-Dummy Placebo-and Active-Controlled, Multicenter Study to Determine the Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/13/2016
Clinical Research Facility
mi
from
Morehead City, NC
Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
A Phase 2, Randomized, Double-Blind, Double-Dummy Placebo-and Active-Controlled, Multicenter Study to Determine the Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/13/2016
Clinical Research Facility
mi
from
Morehead City, NC
Click here to add this to my saved trials
Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
A Phase 2, Randomized, Double-Blind, Double-Dummy Placebo-and Active-Controlled, Multicenter Study to Determine the Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/13/2016
Clinical Research Facility
mi
from
Statesville, NC
Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
A Phase 2, Randomized, Double-Blind, Double-Dummy Placebo-and Active-Controlled, Multicenter Study to Determine the Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/13/2016
Clinical Research Facility
mi
from
Statesville, NC
Click here to add this to my saved trials
Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
A Phase 2, Randomized, Double-Blind, Double-Dummy Placebo-and Active-Controlled, Multicenter Study to Determine the Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/13/2016
Clinical Research Facility
mi
from
Winston-Salem, NC
Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
A Phase 2, Randomized, Double-Blind, Double-Dummy Placebo-and Active-Controlled, Multicenter Study to Determine the Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/13/2016
Clinical Research Facility
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
A Phase 2, Randomized, Double-Blind, Double-Dummy Placebo-and Active-Controlled, Multicenter Study to Determine the Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/13/2016
Clinical Research Facility
mi
from
Carlisle, OH
Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
A Phase 2, Randomized, Double-Blind, Double-Dummy Placebo-and Active-Controlled, Multicenter Study to Determine the Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/13/2016
Clinical Research Facility
mi
from
Carlisle, OH
Click here to add this to my saved trials
Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
A Phase 2, Randomized, Double-Blind, Double-Dummy Placebo-and Active-Controlled, Multicenter Study to Determine the Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/13/2016
Clinical Research Facility
mi
from
Cleveland, OH
Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
A Phase 2, Randomized, Double-Blind, Double-Dummy Placebo-and Active-Controlled, Multicenter Study to Determine the Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/13/2016
Clinical Research Facility
mi
from
Cleveland, OH
Click here to add this to my saved trials
Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
A Phase 2, Randomized, Double-Blind, Double-Dummy Placebo-and Active-Controlled, Multicenter Study to Determine the Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/13/2016
Clinical Research Facility
mi
from
Columbus, OH
Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
A Phase 2, Randomized, Double-Blind, Double-Dummy Placebo-and Active-Controlled, Multicenter Study to Determine the Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/13/2016
Clinical Research Facility
mi
from
Columbus, OH
Click here to add this to my saved trials
Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
A Phase 2, Randomized, Double-Blind, Double-Dummy Placebo-and Active-Controlled, Multicenter Study to Determine the Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/13/2016
Clinical Research Facility
mi
from
Perrysburg, OH
Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
A Phase 2, Randomized, Double-Blind, Double-Dummy Placebo-and Active-Controlled, Multicenter Study to Determine the Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/13/2016
Clinical Research Facility
mi
from
Perrysburg, OH
Click here to add this to my saved trials
Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
A Phase 2, Randomized, Double-Blind, Double-Dummy Placebo-and Active-Controlled, Multicenter Study to Determine the Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/13/2016
Clinical Research Facility
mi
from
Norman, OK
Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
A Phase 2, Randomized, Double-Blind, Double-Dummy Placebo-and Active-Controlled, Multicenter Study to Determine the Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/13/2016
Clinical Research Facility
mi
from
Norman, OK
Click here to add this to my saved trials
Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
A Phase 2, Randomized, Double-Blind, Double-Dummy Placebo-and Active-Controlled, Multicenter Study to Determine the Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/13/2016
Clinical Research Facility
mi
from
Oklahoma City, OK
Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
A Phase 2, Randomized, Double-Blind, Double-Dummy Placebo-and Active-Controlled, Multicenter Study to Determine the Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/13/2016
Clinical Research Facility
mi
from
Oklahoma City, OK
Click here to add this to my saved trials